Clare Taylor

4.7k total citations
15 papers, 942 citations indexed

About

Clare Taylor is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Clare Taylor has authored 15 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Clare Taylor's work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). Clare Taylor is often cited by papers focused on CAR-T cell therapy research (10 papers), Virus-based gene therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). Clare Taylor collaborates with scholars based in United States, United Kingdom and Italy. Clare Taylor's co-authors include Dorothy H. Crawford, Tanzina Haque, P L Amlot, Gwen Wilkie, Isabelle Rivière, Michel Sadelain, Anthony J. Swerdlow, Dilani Dombagoda, Shirley Bartido and Renier J. Brentjens and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Clare Taylor

15 papers receiving 925 citations

Peers

Countries citing papers authored by Clare Taylor

Since Specialization

Citations

This map shows the geographic impact of Clare Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Taylor more than expected).

Fields of papers citing papers by Clare Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Taylor. The network helps show where Clare Taylor may publish in the future.

Co-authorship network of co-authors of Clare Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Taylor. A scholar is included among the top collaborators of Clare Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Taylor. Clare Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation 2014 ·Blood ·Farid Boulad, Xiuyan Wang, Jinrong Qu, Clare Taylor, (unknown), (unknown), Shirley Bartido, Patricia J. Giardina, Glenn Heller, Susan E. Prockop, Aurelio Maggio, Michel Sadelain, Isabelle Rivière	51
2	Phase I Trial Of Autologous CD19-Targeted CAR-Modified T Cells As Consolidation After Purine Analog-Based First-Line Therapy In Patients With Previously Untreated CLL 2013 ·Blood ·Jae H. Park, Isabelle Rivière, Xiuyan Wang, Jolanta Stefanski, Qing He, Oriana Bórquez-Ojeda, Teresa Wasielewska, Clare Taylor, Jinrong Qu, Shirley Bartido, Yvette Bernal, Michel Sadelain, Renier J. Brentjens	7
3	Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy 2013 ·Blood ·Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jolanta Stefanski, Qing He, Oriana Bórquez-Ojeda, Clare Taylor, Teresa Wasielewska, Jinrong Qu, Diana Bouhassira, Yvette Bernal, Sarah Yoo, Terence J. Purdon, Elizabeth Halton, (unknown), Jae H. Park, Kevin J. Curran, Michel Sadelain, Renier J. Brentjens	5
4	CD19 Targeted Allogeneic EBV-Specific T Cells for the Treatment of Relapsed ALL in Pediatric Patients Post HSCT 2012 ·Blood ·Kevin J. Curran, Nancy A. Kernan, Xiuyan Wang, Clare Taylor, Ekaterina Doubrovina, Shirley Bartido, Michel Sadelain, Richard J. O’Reilly, Renier J. Brentjens, Isabelle Rivière	7
5	Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19–28z CAR-Targeted T Cells 2012 ·Blood ·Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Jae H. Park, Jolanta Stefanski, Clare Taylor, Qing He, Malgorzata Olszewska, Teresa Wasielewska, Oriana Bórquez-Ojeda, Jinrong Qu, Shirley Bartido, Joseph G. Jurcic, Dan Douer, Mark G. Frattini, Michel Sadelain, Renier J. Brentjens	1
6	Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL 2012 ·Blood ·Jae H. Park, Isabelle Rivière, Xiuyan Wang, Jolanta Stefanski, Qing He, Clare Taylor, Malgorzata Olszewska, Teresa Wasielewska, Shirley Bartido, Marco L. Davila, Yvette Bernal, Nicole Lamanna, Ariela Noy, Michel Sadelain, Renier J. Brentjens	10
7	Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed CAR+ T cells. 2012 ·Journal of Clinical Oncology ·Susan F. Slovin, Xiuyan Wang, Oriana Bórquez-Ojeda, Jolanta Stefanski, Malgorzata Olszewska, Clare Taylor, Shirley Bartido, Howard I. Scher, Michel Sadelain, Isabelle Rivière	7
8	Virus Specific T-Lymphocytes Genetically Modified to Target the CD19 Antigen Eradicates Systemic Lymphoma In Mice 2010 ·Blood ·Kevin J. Curran, Clare Taylor, Ekaterina Doubrovina, Xiuyan Wang, Richard J. O’Reilly, Michel Sadelain, Nancy A. Kernan, Renier J. Brentjens, Isabelle Rivière	1
9	Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy 2009 ·Journal of Immunotherapy ·Daniel Hollyman, Jolanta Stefanski, Mark Przybylowski, Shirley Bartido, Oriana Bórquez-Ojeda, Clare Taylor, Raymond Yeh, (unknown), Malgorzata Olszewska, (unknown), Michel Sadelain, Renier J. Brentjens, Isabelle Rivière	234
10	Enhanced In Vivo activation of Adoptively Transferred Genetically Targeted T Cells Following Cyclophosphamide Chemotherapy: Initial Results From a Phase I Clinical Trial Treating CLL Patients with Autologous CD19-Targeted T Cells. 2009 ·Blood ·Renier J. Brentjens, Daniel Hollyman, Jae H. Park, Elmer Santos, Raymond Yeh, Jolanta Stefanski, Clare Taylor, Mark A. Weiss, Daniel A. Filippa, Isabelle Rivière, Michel Sadelain	1
11	Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy 2007 ·Clinical Cancer Research ·Clare Taylor, Dawn L. Hershman, Nina Shah, Nicole Suciu‐Foca, (unknown), Robert N. Taub, Linda T. Vahdat, Bin Cheng, Mark D. Pegram, Keith L. Knutson, Raphael Clynes	167
12	Multifactorial Optimization of Gammaretroviral Gene Transfer into Human T Lymphocytes for Clinical Application 2007 ·Human Gene Therapy ·Alfonso Quintás‐Cardama, Raymond Yeh, Daniel Hollyman, Jolanta Stefanski, Clare Taylor, Yan Nikhamin, Gavin H. Imperato, Michel Sadelain, Isabelle Rivière, Renier J. Brentjens	26
13	Establishment and Characterization of a Bank of Cytotoxic T Lymphocytes for Immunotherapy of Epstein-Barr Virus-Associated Diseases 2004 ·Journal of Immunotherapy ·Gwen Wilkie, Clare Taylor, (unknown), David Burns, Marc Turner, David R. Kilpatrick, P L Amlot, Dorothy H. Crawford, Tanzina Haque	62
14	Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells 2002 ·The Lancet ·Tanzina Haque, Gwen Wilkie, Clare Taylor, P L Amlot, (unknown), (unknown), Dilani Dombagoda, (unknown), Anthony J. Swerdlow, Dorothy H. Crawford	271
15	COMPLETE REGRESSION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE USING PARTIALLY HLA-MATCHED EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS1 2001 ·Transplantation ·Tanzina Haque, Clare Taylor, Gwen Wilkie, (unknown), P L Amlot, Sue V. Beath, Patrick McKiernan, Dorothy H. Crawford	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact